Digital Health Singapore

Singapore AI in Ophthalmology Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Singapore AI in Ophthalmology Market Industry Trends and Forecast to 2034: Segmented by (Application, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $0.5 Mn Placeholder estimate
Estimate 2025 $0.7 Mn 0.1% of the global market
Projected 2034 $6.0 Mn 815.9% Adds $5.3 Mn over 9 forecast years
CAGR 2025–2034 27.9% Faster than 88% of 103 Digital Health markets here
Key players 5
  • Singapore is 0.14% of the global market.
  • In APAC, the largest is China at $42.6 Mn.
  • Fastest growing: India at 30.2% a year.
  • Singapore ranks 9th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$5.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
AI in Ophthalmology Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $0.5 Mn — —
2025 (base) $0.7 Mn +$0.1 Mn —
2026 (forecast) $0.8 Mn +$0.2 Mn +27.9%
2027 (forecast) $1.1 Mn +$0.2 Mn +63.6%
2028 (forecast) $1.4 Mn +$0.3 Mn +109.2%
2029 (forecast) $1.8 Mn +$0.4 Mn +167.6%
2030 (forecast) $2.2 Mn +$0.5 Mn +242.3%
2031 (forecast) $2.9 Mn +$0.6 Mn +337.7%
2032 (forecast) $3.7 Mn +$0.8 Mn +459.9%
2033 (forecast) $4.7 Mn +$1.0 Mn +616.1%
2034 (forecast) $6.0 Mn +$1.3 Mn +815.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Singapore AI in Ophthalmology Market Analysis at a glance
Market size, 2025$0.7 Mn placeholder estimate
Forecast, 2034$6.0 Mn placeholder estimate
Growth (CAGR), 2025–203427.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication and setting (see all)
Key playersDigital Diagnostics, Eyenuk, Google Health, Topcon, RetinAI (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore AI in Ophthalmology Market Analysis Executive Summary

AI in ophthalmology reads retinal scans to screen for diabetic eye disease, glaucoma and macular degeneration.

Key segments of the AI in Ophthalmology market include application (Diabetic Retinopathy Screening, Glaucoma and Macular Degeneration) and setting (Eye Clinics, Primary Care and Pharmacies).

Bar chart: Singapore AI in Ophthalmology market size, 2024–2034, placeholder estimates. $0.5 Mn in 2024, $0.7 Mn in 2025 and $6.0 Mn in 2034, 27.9% CAGR.
Singapore AI in Ophthalmology market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore AI in Ophthalmology Market Dynamics

Market Growth Drivers

Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Ophthalmology market. Health systems are moving from pilots to wider use.

Opportunity

Generative AI, automation of paperwork and AI tools approved as medical devices give the AI in Ophthalmology market strong growth, including in emerging health systems.

Market Restraints

Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI in Ophthalmology market.

Competitive Landscape for AI in Ophthalmology Market in Singapore

The AI in Ophthalmology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for AI in Ophthalmology Market in Singapore

AI in Ophthalmology in Singapore: payment

MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[1]

[1] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI in Ophthalmology market. Government digital health programs in Singapore are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in AI in Ophthalmology right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

AI in Ophthalmology in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 17 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 8th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the AI in Ophthalmology market in Singapore?
Placeholder estimate: about $0.7 Mn in 2025, rising to about $6.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the AI in Ophthalmology market in Singapore growing?
Placeholder estimate: about 27.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the AI in Ophthalmology market report cover?
The report splits the market by application (Diabetic Retinopathy Screening, Glaucoma, Macular Degeneration) and setting (Eye Clinics, Primary Care, Pharmacies).
Who are the key players in the AI in Ophthalmology market?
Key players include Digital Diagnostics, Eyenuk, Google Health, Topcon and RetinAI.
What is driving the AI in Ophthalmology market?
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Ophthalmology market. Health systems are moving from pilots to wider use.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
How much research is published on AI in Ophthalmology?
PubMed lists 80 papers on AI in Ophthalmology added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Singapore

See all

Related on artificial intelligence and eye health

See the topic